Beruflich Dokumente
Kultur Dokumente
Overview
2500 25
2000 20
Net Sales Turnover (in Cr.)
1500 15
Margin
1000 10
500 5
0 0
Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17
Net Sales Turnover (in Cr.) Operating Margin (RHS) Net Profit Margin (RHS)
Revenue decreased by 9.46% to Rs. 1462.23 Cr in Q3FY17 when compared to the previous quarter. On the other hand, it rose by 14.98%
when compared with Q3FY16. The Sales had been increasing from Q1FY17 to Q2FY17. The Sales decreased in Q4FY16 and Q3FY17.
EBITDA was Rs. 293.52 Cr for Q3FY17, a drop of 14.77% compared to Q2FY17.It rose by 15.61% compared to Q3FY16 . The EBITDA had
been increasing from Q1FY17 to Q2FY17. The EBITDA decreased in Q4FY16 and Q3FY17. PAT for Q3FY17 was Rs. 236.26 Cr, a fall of
18.01% when compared to Q2FY17 . The PAT had been increasing from Q1FY17 to Q2FY17. The PAT decreased in Q3FY17. It plummeted in
Q4FY16.
300
The EBITDA Margin decreased to 20.07% in Q3FY17, a fall of 125.0
bps compared to the last quarter. It was due to the rise in employee
and other expenses as a proportion of sales. The EBITDA Margin
250
was 19.96% same quarter last year. PAT Margin fell from 17.51% in
Q2FY17 to 15.96% this quarter. It fell due to the drop in EBITDA
Margin , depreciation, tax and interest.
200
Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17
EPS Trend
20
10
The stock price of Alkem Laboratories Ltd increased from Rs.
1660.3 to Rs. 1874.8 when compared to the previous quarter.
0
Q3FY16 Q4FY16 Q1FY17 Q2FY17 Q3FY17
EPS Trend
Stock Price
1900
1800
Stock Price
1700
1600
1500
0
4
-3
-1
-2
-2
-1
-2
-0
-1
-2
-1
-2
-0
-1
-1
09
10
10
10
11
11
12
12
12
01
01
02
02
02
-
-
16
16
16
16
16
16
16
16
16
17
17
17
17
17
20
20
20
20
20
20
20
20
20
20
20
20
20
Stock Price 20
Gross Sales 1462.23 1271.74 15 1615.01 -9.46
Net Profit after Minority Interest & P/L Asso.Co. 233.4 186.89 24.9 282.83 -17.48
Adjusted Profit After Extra-ordinary item 233.4 186.89 24.9 282.83 -17.48
Basic:
Diluted:
EPS before Exceptional/Extraordinary items-Diluted 19.52 15.63 24.9 23.65 -17.46